65
Views
72
CrossRef citations to date
0
Altmetric
Signal Transduction

The Phosphatidylinositol 3-Phosphate Phosphatase Myotubularin- Related Protein 6 (MTMR6) Is a Negative Regulator of the Ca2+-Activated K+ Channel KCa3.1

, , , , , & show all
Pages 3630-3638 | Received 27 Aug 2004, Accepted 31 Jan 2005, Published online: 27 Mar 2023

REFERENCES

  • Becker, E., U. Huynh-Do, S. Holland, T. Pawson, T. O. Daniel, and E. Y. Skolnik. 2000. Nck-interacting Ste20 kinase couples Eph receptors to c-Jun N-terminal kinase and integrin activation. Mol. Cell. Biol. 20:1537–1545.
  • Benzaquen, L. R., C. Brugnara, H. R. Byers, S. Gatton-Celli, and J. A. Halperin. 1995. Clotrimazole inhibits cell proliferation in vitro and in vivo. Nat. Med. 1:534–540.
  • Bolino, A., M. Muglia, F. L. Conforti, E. LeGuern, M. A. Salih, D. M. Georgiou, K. Christodoulou, I. Hausmanowa-Petrusewicz, P. Mandich, A. Schenone, A. Gambardella, F. Bono, A. Quattrone, M. Devoto, and A. P. Monaco. 2000. Charcot-Marie-Tooth type 4B is caused by mutations in the gene encoding myotubularin-related protein-2. Nat. Genet. 25:17–19. [Online.]
  • Bond, C. T., J. Maylie, and J. P. Adelman. 1999. Small-conductance calcium-activated potassium channels. Ann. N. Y. Acad. Sci. 868:370–378.
  • Cahalan, M. D., H. Wulff, and K. G. Chandy. 2001. Molecular properties and physiological roles of ion channels in the immune system. J. Clin. Immunol. 21:235–252.
  • Catterall, W. A., K. G. Chandy, D. E. Clapham, G. A. Gutman, F. Hofmann, A. J. Harmar, D. R. Abernethy, and M. Spedding. 2003. International union of pharmacology: approaches to the nomenclature of voltage-gated ion channels. Pharmacol. Rev. 55:573–574.
  • Coetzee, W. A., Y. Amarillo, J. Chiu, A. Chow, D. Lau, T. McCormack, H. Moreno, M. S. Nadal, A. Ozaita, D. Pountney, M. Saganich, E. Vega-Saenz de Miera, and B. Rudy. 1999. Molecular diversity of K+ channels. Ann. N. Y. Acad. Sci. 868:233–285.
  • Dang, H., Z. Li, E. Y. Skolnik, and H. Fares. 2004. Disease-related myotubularins function in endocytic traffic in Caenorhabditis elegans. Mol. Biol. Cell 15:189–196.
  • Devor, D. C., A. K. Singh, A. C. Gerlach, R. A. Frizzell, and R. J. Bridges. 1997. Inhibition of intestinal Cl− secretion by clotrimazole: direct effect on basolateral membrane K+ channels. Am. J. Physiol. 273:C531–C540.
  • Doerks, T., M. Strauss, M. Brendel, and P. Bork. 2000. GRAM, a novel domain in glucosyltransferases, myotubularins and other putative membrane-associated proteins. Trends Biochem. Sci. 25:483–485.
  • Fanger, C. M., S. Ghanshani, N. J. Logsdon, H. Rauer, K. Kalman, J. Zhou, K. Beckingham, K. G. Chandy, M. D. Cahalan, and J. Aiyar. 1999. Calmodulin mediates calcium-dependent activation of the intermediate conductance KCa channel, IKCa1. J. Biol. Chem. 274:5746–5754.
  • Fanger, C. M., H. Rauer, A. L. Neben, M. J. Miller, H. Wulff, J. C. Rosa, C. R. Ganellin, K. G. Chandy, and M. D. Cahalan. 2001. Calcium-activated potassium channels sustain calcium signaling in T lymphocytes. Selective blockers and manipulated channel expression levels. J. Biol. Chem. 276:12249–12256.
  • Gerlach, A. C., N. N. Gangopadhyay, and D. C. Devor. 2000. Kinase-dependent regulation of the intermediate conductance, calcium-dependent potassium channel, hIK1. J. Biol. Chem. 275:585–598.
  • Gerlach, A. C., C. A. Syme, L. Giltinan, J. P. Adelman, and D. C. Devor. 2001. ATP-dependent activation of the intermediate conductance, Ca2+-activated K+ channel, hIK1, is conferred by a C-terminal domain. J. Biol. Chem. 276:10963–10970.
  • Ghanshani, S., H. Wulff, M. J. Miller, H. Rohm, A. Neben, G. A. Gutman, M. D. Cahalan, and K. G. Chandy. 2000. Up-regulation of the IKCa1 potassium channel during T-cell activation. Molecular mechanism and functional consequences. J. Biol. Chem. 275:37137–37149.
  • Hamilton, K. L., C. A. Syme, and D. C. Devor. 2003. Molecular localization of the inhibitory arachidonic acid binding site to the pore of hIK1. J. Biol. Chem. 278:16690–16697.
  • Hilgemann, D. W. 2004. Biochemistry. Oily barbarians breach ion channel gates. Science 304:223–224.
  • Hilgemann, D. W., S. Feng, and C. Nasuhoglu. 2001. The complex and intriguing lives of PIP2 with ion channels and transporters. Sci STKE 2001:RE19. [Online.]
  • Ishii, T. M., C. Silvia, B. Hirschberg, C. T. Bond, J. P. Adelman, and J. Maylie. 1997. A human intermediate conductance calcium-activated potassium channel. Proc. Natl. Acad. Sci. USA 94:11651–11656.
  • Izu, L. T., S. L. McCulle, M. T. Ferreri-Jacobia, D. C. Devor, and M. E. Duffey. 2002. Vasoactive intestinal peptide-stimulated Cl− secretion: activation of cAMP-dependent K+ channels. J. Membr. Biol. 186:145–157.
  • Jensen, B., M. Hertz, P. Christophersen, and L. Madsen. 2002. The Ca2+-activated K+ channel of intermediate conductance: a possible target for immune suppression. Expert Opin. Ther. Targets 6:623–636.
  • Joiner, W. J., L. Y. Wang, M. D. Tang, and L. K. Kaczmarek. 1997. hSK4, a member of a novel subfamily of calcium-activated potassium channels. Proc. Natl. Acad. Sci. USA 94:11013–11018.
  • Khanna, R., M. C. Chang, W. J. Joiner, L. K. Kaczmarek, and L. C. Schlichter. 1999. hSK4/hIK1, a calmodulin-binding KCa channel in human T lymphocytes. Roles in proliferation and volume regulation. J. Biol. Chem. 274:14838–14849.
  • Kim, S.-A., P. O. Vacratsis, R. Firestein, M. L. Cleary, and J. E. Dixon. 2003. Regulation of myotubularin-related (MTMR)2 phosphatidylinositol phosphatase by MTMR5, a catalytically inactive phosphatase. Proc. Natl. Acad. Sci. USA 100:4492–4497.
  • Koegel, H., and C. Alzheimer. 2001. Expression and biological significance of Ca2+-activated ion channels in human keratinocytes. FASEB J. 15:145–154.
  • Koegel, H., S. Kaesler, R. Burgstahler, S. Werner, and C. Alzheimer. 2003. Unexpected down-regulation of the hIK1 Ca2+-activated K+ channel by its opener 1-ethyl-2-benzimidazolinone in HaCaT keratinocytes. Inverse effects on cell growth and proliferation. J. Biol. Chem. 278:3323–3330.
  • Kohler, R., H. Wulff, I. Eichler, M. Kneifel, D. Neumann, A. Knorr, I. Grgic, D. Kampfe, H. Si, J. Wibawa, R. Real, K. Borner, S. Brakemeier, H. D. Orzechowski, H. P. Reusch, M. Paul, K. G. Chandy, and J. Hoyer. 2003. Blockade of the intermediate-conductance calcium-activated potassium channel as a new therapeutic strategy for restenosis. Circulation 108:1119–1125.
  • Laporte, J., F. Bedez, A. Bolino, and J. L. Mandel. 2003. Myotubularins, a large disease-associated family of cooperating catalytically active and inactive phosphoinositides phosphatases. Hum. Mol. Genet. 12(Spec. no. 2):R285–R292.
  • Laporte, J., F. Blondeau, A. Gansmuller, Y. Lutz, J. L. Vonesch, and J. L. Mandel. 2002. The PtdIns3P phosphatase myotubularin is a cytoplasmic protein that also localizes to Rac1-inducible plasma membrane ruffles. J. Cell Sci. 115:3105–3117.
  • Laporte, J., L. J. Hu, C. Kretz, J. L. Mandel, P. Kioschis, J. F. Coy, S. M. Klauck, A. Poustka, and N. Dahl. 1996. A gene mutated in X-linked myotubular myopathy defines a new putative tyrosine phosphatase family conserved in yeast. Nat. Genet. 13:175–182.
  • Lupas, A., M. Van Dyke, and J. Stock. 1991. Predicting coiled coils from protein sequences. Science 252:1162–1164.
  • Maher, A. D., and P. W. Kuchel. 2003. The Gardos channel: a review of the Ca2+-activated K+ channel in human erythrocytes. Int. J. Biochem. Cell Biol. 35:1182–1197.
  • Mochizuki, Y., and P. W. Majerus. 2003. Characterization of myotubularin-related protein 7 and its binding partner, myotubularin-related protein 9. Proc. Natl. Acad. Sci. USA 100:9768–9773.
  • Nandurkar, H. H., M. Layton, J. Laporte, C. Selan, L. Corcoran, K. K. Caldwell, Y. Mochizuki, P. W. Majerus, and C. A. Mitchell. 2003. Identification of myotubularin as the lipid phosphatase catalytic subunit associated with the 3-phosphatase adapter protein, 3-PAP. Proc. Natl. Acad. Sci. USA 100:8660–8665.
  • Parihar, A. S., M. J. Coghlan, M. Gopalakrishnan, and C. C. Shieh. 2003. Effects of intermediate-conductance Ca2+-activated K+ channel modulators on human prostate cancer cell proliferation. Eur. J. Pharmacol. 471:157–164.
  • Schumacher, M. A., A. F. Rivard, H. P. Bachinger, and J. P. Adelman. 2001. Structure of the gating domain of a Ca2+-activated K+ channel complexed with Ca2+/calmodulin. Nature 410:1120–1124.
  • Senderek, J., C. Bergmann, S. Weber, U. P. Ketelsen, H. Schorle, S. Rudnik-Schoneborn, R. Buttner, E. Buchheim, and K. Zerres. 2003. Mutation of the SBF2 gene, encoding a novel member of the myotubularin family, in Charcot-Marie-Tooth neuropathy type 4B2/11p15. Hum. Mol. Genet. 12:349–356.
  • Syme, C. A., K. L. Hamilton, H. M. Jones, A. C. Gerlach, L. Giltinan, G. D. Papworth, S. C. Watkins, N. A. Bradbury, and D. C. Devor. 2003. Trafficking of the Ca2+-activated K+ channel, hIK1, is dependent upon a C-terminal leucine zipper. J. Biol. Chem. 278:8476–8486.
  • Wishart, M. J., G. S. Taylor, J. T. Slama, and J. E. Dixon. 2001. PTEN and myotubularin phosphoinositide phosphatases: bringing bioinformatics to the lab bench. Curr. Opin. Cell Biol. 13:172–181.
  • Wulff, H., C. Beeton, and K. G. Chandy. 2003. Potassium channels as therapeutic targets for autoimmune disorders. Curr. Opin. Drug Discov. Devel. 6:640–647.
  • Wulff, H., H. G. Knaus, M. Pennington, and K. G. Chandy. 2004. K+ channel expression during B cell differentiation: implications for immunomodulation and autoimmunity. J. Immunol. 173:776–786.
  • Xue, Y., H. Fares, B. Grant, Z. Li, A. M. Rose, S. G. Clark, and E. Y. Skolnik. 2003. Genetic analysis of the myotubularin family of phosphatases in Caenorhabditis elegans. J. Biol. Chem. 278:34380–34386.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.